Outset Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	119.48	113.69	130.38	115.38	102.6
Revenue Growth (YoY)	5.09%	-12.80%	13.00%	12.45%	105.47%
Cost of Revenue	72.72	74.55	101.25	97.54	94.99
Gross Profit	46.75	39.14	29.13	17.83	7.61
Selling, General & Admin	92.27	110.67	139.8	130	101.39
Research & Development	21.2	36.29	56.57	48.86	36.74
Operating Expenses	113.47	146.96	196.37	178.85	138.13
Operating Income	-66.71	-107.82	-167.24	-161.02	-130.52
Interest Expense	-13.95	-23.87	-12.68	-3.57	-1.72
Interest & Investment Income	7.41	9.76	10.17	3.29	0.5
EBT Excluding Unusual Items	-73.26	-121.93	-169.74	-161.29	-131.74
Merger & Restructuring Charges	0.01	-5.56	-2.53	-	-
Other Unusual Items	-7.69	-	-	-1.37	-
Pretax Income	-80.94	-127.49	-172.27	-162.66	-131.74
Income Tax Expense	0.72	0.49	0.52	0.3	0.2
Earnings From Continuing Operations	-81.65	-127.98	-172.8	-162.96	-131.94
Net Income	-81.65	-127.98	-172.8	-162.96	-131.94
Net Income to Common	-81.65	-127.98	-172.8	-162.96	-131.94
Shares Outstanding (Basic)	15	3	3	3	3
Shares Outstanding (Diluted)	15	3	3	3	3
Shares Change (YoY)	339.24%	4.78%	2.94%	5.64%	178.69%
EPS (Basic)	-5.37	-36.96	-52.28	-50.75	-43.41
EPS (Diluted)	-5.37	-36.96	-52.28	-50.75	-43.41
Free Cash Flow	-47.13	-117.22	-134.81	-154.05	-133.37
Free Cash Flow Per Share	-3.10	-33.85	-40.79	-47.98	-43.88
Gross Margin	39.13%	34.43%	22.34%	15.46%	7.41%
Operating Margin	-55.84%	-94.84%	-128.27%	-139.56%	-127.21%
Profit Margin	-68.34%	-112.57%	-132.54%	-141.24%	-128.59%
Free Cash Flow Margin	-39.44%	-103.10%	-103.40%	-133.53%	-129.99%
EBITDA	-62.37	-102.09	-161.43	-155.85	-125.36
EBITDA Margin	-52.20%	-89.80%	-123.82%	-135.08%	-122.18%
D&A For EBITDA	4.34	5.73	5.81	5.17	5.16
EBIT	-66.71	-107.82	-167.24	-161.02	-130.52
EBIT Margin	-55.84%	-94.84%	-128.27%	-139.56%	-127.21%
Revenue as Reported	119.48	113.69	130.38	115.38	102.6

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q